US girls to receive HPV vaccine but picture unclear on potential worldwide use, acceptance.
R Twombly - JNCI: Journal of the National Cancer Institute, 2006 - search.ebscohost.com
R Twombly
JNCI: Journal of the National Cancer Institute, 2006•search.ebscohost.comThe article reports on the US Centers for Disease Control and Prevention's recommendation
that US girls ages 11 and 12 receive a vaccine that prevents infection by the most common
strains of the human papillomavirus (HPV), which accounts for 70 percent of cervical cancer.
The three-shot series of Merck's Gardasil costs $360. Whether the HPV vaccine should be
mandated in school-age children will be up for the states to decide.
that US girls ages 11 and 12 receive a vaccine that prevents infection by the most common
strains of the human papillomavirus (HPV), which accounts for 70 percent of cervical cancer.
The three-shot series of Merck's Gardasil costs $360. Whether the HPV vaccine should be
mandated in school-age children will be up for the states to decide.
Abstract
The article reports on the US Centers for Disease Control and Prevention's recommendation that US girls ages 11 and 12 receive a vaccine that prevents infection by the most common strains of the human papillomavirus (HPV), which accounts for 70 percent of cervical cancer. The three-shot series of Merck's Gardasil costs $360. Whether the HPV vaccine should be mandated in school-age children will be up for the states to decide.
search.ebscohost.com